Disclosure: This post is published by Tristella Advisors, which is included in the list below. We have made every effort to evaluate each firm using the same criteria we apply to ourselves. Tristella is positioned for a specific type of client (health systems, payers, and medtech organizations with clinical AI strategy, HIPAA-compliant AI governance, or Salesforce Health Cloud needs) and may not be the right choice for other situations.
Healthcare IT strategy consulting is a specific type of engagement, different from implementation, staffing, or operational advisory: it is the work of helping a health system, academic medical center, or payer decide what to build, what to buy, what to prioritize, and how to govern technology decisions across a three-to-five-year horizon. In 2026, that work is increasingly inseparable from AI strategy. Health system CIOs and CMIOs are no longer asking whether to adopt clinical AI. They are asking which use cases to start with, how to govern AI responsibly across a regulated environment, what the build-vs-buy decision looks like for AI-native vendors, and how to structure a roadmap that produces real returns rather than a growing portfolio of underused pilots.
The firms that do this work well vary significantly in how they approach it: some bring top-tier strategy rigor from management consulting; some bring data analytics infrastructure alongside advisory; some bring healthcare market intelligence and forecasting; and some bring deep technical depth in clinical AI and the platforms health systems are deploying. None of them is the right choice for every situation.
This post covers six firms across distinct models and evaluates each on the criteria that matter for healthcare IT strategy specifically. For a broader overview of the healthcare IT consulting landscape, including implementation-focused firms and EHR specialists, the companion healthcare IT consulting firms overview covers that terrain in parallel.
How to evaluate a healthcare IT strategy consulting firm
The evaluation criteria for strategy consulting are different from the criteria for implementation or staffing. You are not buying a team to build something; you are buying a perspective, a methodology, and a set of outputs that should influence how your organization makes decisions for years.
Research depth and proprietary data. Strategy consulting at its best is grounded in data that the client cannot generate internally. Firms with proprietary databases, benchmarking data across hundreds of comparable health systems, or dedicated research centers produce recommendations that are difficult to dismiss as generic best practices. Ask what data the firm actually brings to the engagement, not what it can access through third parties, but what it owns and analyzes continuously.
AI strategy depth vs. general management consulting credentials. Management consulting credentials are table stakes at this level. The question is whether the firm has people who can hold a substantive conversation about clinical AI governance, model validation, agentic AI operating models, HIPAA-compliant data access, and the specific regulatory requirements that apply to AI in clinical workflows. General strategy frameworks applied to healthcare AI produce generic recommendations; genuine AI domain expertise produces specific, defensible guidance.
Clinical and operational integration. Healthcare IT strategy that is disconnected from clinical workflow reality produces roadmaps that encounter implementation resistance the moment execution begins. Firms whose strategists have direct experience in clinical operations, physician engagement, and care delivery understand why technically sound recommendations fail to produce outcomes. Ask specifically about the clinical backgrounds on the engagement team, not just the consulting credentials.
Deliverable format and implementation handoff. A strategy engagement that produces a visually impressive slide deck but no implementation-ready outputs is not complete. Ask what the deliverable looks like, who it is designed for, and how it transitions into execution. A technology strategy roadmap that a CIO can defend to the board and a technology team can execute against is a different deliverable from a thought leadership document designed to impress a procurement committee.
Track record at comparable organizations. A strategy firm that works primarily with large academic medical centers may not understand the constraints of a community health system with a smaller IT team, a tighter budget, and a different governance structure. Ask for references from organizations of similar size, ownership structure, and market position to yours.
The firms
Boutique specialist firms
Tristella Advisors
Tristella is a boutique healthcare IT strategy and clinical AI firm working with health systems, payers, and medtech organizations on the intersection of AI strategy, HIPAA-compliant AI governance, and technology platform decisions. The practice covers clinical AI readiness and governance frameworks, Salesforce Health Cloud and Agentforce strategy and implementation, CMS interoperability compliance advisory, and AI architecture decisions for organizations building or buying AI in clinical and administrative workflows. Engagements are partner-led throughout, meaning the senior practitioner who scopes the strategy is the same person working with the organization on an ongoing basis.
The client profile Tristella serves best is the health system or payer that is past the "should we do AI" question and into "how do we do this responsibly and at scale." That includes organizations evaluating clinical AI vendors who need an independent assessment of vendor claims, organizations that have run AI pilots and need a governance and scaling framework, and organizations implementing Salesforce Health Cloud who need an AI strategy embedded in the platform work rather than as a separate initiative.
The limitation is scope: Tristella does not bring the broad management consulting bench of a large firm, the hospital market intelligence data of a strategic planning specialist, or the extensive benchmarking data of an analytics platform. For engagements that require large-team delivery, broad organizational change management, or market sizing analysis, a different firm model is the right choice.
The healthcare AI adoption scorecard is typically the right starting point for health systems evaluating their AI readiness before committing to a broader strategy engagement.
Tristella healthcare IT strategy and clinical AI services
Top-tier management consulting
McKinsey and Company
McKinsey is the largest global strategy consulting firm and operates one of the most active healthcare practices in the industry, covering providers, payers, life sciences, and healthcare technology. Its healthcare technology and AI practice helps health systems understand the value at stake from digital technologies, build roadmaps for organizational transformation, identify specific use cases where AI can produce measurable clinical and financial returns, and manage the governance and change management complexity of large-scale AI adoption.
McKinsey's differentiation in this space is the combination of analytical rigor, broad comparative data across the healthcare systems it advises globally, and the organizational scale to run complex multi-workstream engagements alongside health system leadership teams. In 2025, McKinsey published research framing healthcare AI as having moved from an "if" to a "how fast and how responsibly" decision, with specific attention to the trade-offs between point-solution AI and modular platform architecture. That framing reflects an engagement practice that has worked through these decisions with large health systems at scale.
McKinsey is the strongest fit for large health systems, academic medical centers, and integrated delivery networks whose technology strategy decisions are board-level questions requiring defensible analytical backing and the credibility that a McKinsey imprimatur provides with governance committees. The limitation is cost and orientation: McKinsey engages at a price point that reflects its brand and team structure, and its model is designed for large organizations with senior leadership bandwidth to partner with a top-tier strategy firm. Community health systems and single-hospital organizations are not the typical McKinsey healthcare technology client, and should be realistic about whether the investment is appropriate for their decision-making context.
Oliver Wyman
Oliver Wyman is a management consulting firm with a dedicated healthcare and life sciences practice that is consistently ranked among the top strategy advisors to the healthcare industry. The firm convenes an annual Health Innovation Summit that brings together senior healthcare executives to work through the decisions shaping AI adoption, care model transformation, and digital strategy, which gives Oliver Wyman practitioners ongoing access to current thinking from the executives they advise. The firm's healthcare work spans provider strategy, payer advisory, health technology strategy, and value-based care transformation.
Oliver Wyman's differentiation is its depth in both the strategy and the analytical sides of healthcare: the firm publishes substantial primary research on AI choices for healthcare leaders, clinical AI implementation barriers, and the governance structures that determine whether AI investments produce outcomes. Its Health Innovation Center works alongside client engagements to bring frameworks that are grounded in current operating reality rather than lagging benchmarks.
Oliver Wyman is the strongest fit for health systems and payers that need a strategy partner whose healthcare depth matches their complexity: organizations making choices about AI investment priorities, care delivery model changes, or digital health vendor portfolios that require structured analytical frameworks and a practitioner perspective grounded in current market dynamics. The limitation is similar to McKinsey: Oliver Wyman is a premium strategy firm, and its engagement model is designed for senior executive partnership at organizations with the scale and governance structure to use strategy consulting effectively.
Big 4 advisory
Deloitte
Deloitte operates one of the largest healthcare consulting practices among the major professional services firms, with specific depth in healthcare AI strategy through its Applied AI and Digital Analytics practice and its dedicated Center for Health Solutions research unit. Deloitte advises health systems and health plans on identifying AI use cases, implementing AI governance frameworks, and building the operating model changes that agentic AI requires across clinical and administrative workflows. The firm's 2025 research on healthcare AI adoption surveyed 100 technology executives from large US health systems and health plans, giving its recommendations empirical grounding in current market behavior.
Deloitte's differentiation is the combination of strategy advisory, technology implementation capability, and ongoing regulatory compliance expertise under one firm. For health systems that need a strategy engagement to lead directly into implementation and compliance work, Deloitte's integrated model is an advantage over pure-play strategy boutiques that cannot resource the execution. The firm's 2026 Healthcare Outlook highlights AI and digital partnerships as the primary areas where health system leaders are investing to outperform peers, framing AI strategy as increasingly central to competitive position rather than experimental.
Deloitte is the strongest fit for large health systems and health plans that want a single firm relationship covering strategy, technology advisory, implementation oversight, and regulatory compliance. Organizations for whom the transition from strategy to execution is a key risk, those who have experienced strategy recommendations that did not survive implementation contact, will find value in a firm that does both. The limitation is that Deloitte's scale and multi-function model means practitioner depth in any specific area varies; for organizations whose primary need is deep clinical AI governance expertise or specific platform depth (Salesforce Health Cloud, Epic, Oracle Health), a specialist firm alongside a Big 4 relationship often produces better outcomes than either alone.
Analytics platform with embedded consulting
Health Catalyst
Health Catalyst is a healthcare analytics company that combines a data platform with embedded consulting and professional services, creating an advisory model that is distinct from traditional strategy consulting. The firm's Data Operating System (DOS) aggregates clinical, financial, and operational data across a health system's environment, and its analytics applications and consulting services sit on top of that unified data layer. This means Health Catalyst's strategy recommendations emerge from analysis of the client's actual data, not from benchmarks against other organizations' data.
Health Catalyst's differentiating strength in IT strategy is its value-based care analytics practice: for health systems making decisions about population health investment, care management priorities, and contract structure under value-based arrangements, the combination of analytics capability and strategic advisory produces guidance that is directly connected to the data that will be used to execute it. The firm's Value Optimizer platform provides population health analytics across more than ten domains, giving strategy recommendations a quantitative grounding that pure strategy consulting cannot replicate.
Health Catalyst is the strongest fit for health systems that have already invested in data analytics infrastructure and want a strategy advisory relationship that is embedded in that infrastructure rather than operating alongside it. Organizations evaluating where to focus AI investment in a value-based care context, and those who need their strategy recommendations to connect directly to operational metrics, will find the analytics-plus-consulting model valuable. The limitation is the model dependency: Health Catalyst's consulting is most powerful when the client uses its data platform. Organizations that are evaluating IT strategy advisory before committing to a specific analytics vendor should consider whether a platform-embedded advisory creates conflicts in that evaluation.
Market intelligence and strategic planning
Sg2 by Vizient
Sg2 is a healthcare market intelligence and strategic planning firm, now part of Vizient, the largest member-driven healthcare performance improvement company in the country. Sg2's core offering is data-driven strategic planning for health systems and hospitals: market analytics, service line strategy, demand forecasting, and competitive positioning analysis that helps health system leadership teams make capital allocation, service line development, and network strategy decisions with quantitative market grounding.
In technology and AI strategy specifically, Sg2 has positioned itself around readiness and governance as the primary challenges for health systems deploying AI at scale, with research indicating that the largest barrier to AI adoption is not technology access but organizational readiness: governance structures, data quality, and enterprise alignment. Its 2025 Impact of Change Forecast projects 18 percent growth in outpatient volumes and 5 percent growth in inpatient discharges over the next decade, providing the market context that sits beneath IT investment decisions.
Sg2 is the strongest fit for health system strategy and planning teams that need market analytics and forecasting to support IT investment decisions: organizations for whom the strategic planning process and the technology investment process need to be connected rather than run in parallel. For decisions about where to deploy AI in service line management, access strategy, or capacity planning, Sg2's market intelligence layer provides context that technology-focused advisors typically lack. The limitation is scope: Sg2's strength is market analytics and strategic planning, not clinical AI governance, platform selection, or implementation advisory. Organizations whose IT strategy questions are primarily technical rather than market-positioning should pair a Sg2 relationship with a technology-focused advisor.
How to choose
The clearest filter is what kind of question your organization is trying to answer.
If the question is "how do we govern clinical AI responsibly, choose the right vendors, and build a HIPAA-compliant AI architecture": a firm with genuine clinical AI depth, either a specialist boutique or a Big 4 firm with dedicated AI advisory, serves this better than a generalist strategy consultant.
If the question is "where should we invest at the board level to position competitively in a changing market": McKinsey or Oliver Wyman provide the analytical rigor and comparative perspective that board-level strategy decisions require, and their brand carries weight in governance processes.
If the question is "how do we structure our AI investment to produce measurable returns in a value-based care environment": Health Catalyst's analytics-embedded model connects strategy to the data systems that will measure it.
If the question is "what does our service line and technology strategy look like given projected market demand": Sg2's forecasting and market intelligence layer provides context that pure technology advisors do not bring.
For the full framework of what healthcare IT strategy consulting engagements typically cover and how they are priced, the healthcare IT strategy consulting cost post covers what you are buying across different engagement structures and what rates to expect at each level.
Myra Salapare leads Tristella's healthcare IT strategy and clinical AI practice. If Tristella's profile fits what your organization needs, contact us to discuss scope and engagement structure.
Related reading: